Groups of British scientists have developed a drug that allows a person to deal with the syndrome associated with frequent flights and night work, when the body is not able to cope with an abrupt change of regime. It was found that there is a special enzyme that regulates the work of the "biological clock" of man. By suppressing the action of this enzyme, you can influence the “reset” of the internal clock of the human body, thus accelerating its adaptation to a change in mode.
The developed tablet, called CK1 Epsilon, can also have a saving effect on the human heart, protecting it from overloading.
It was revealed that even the strongest people are sometimes unable to withstand frequent regime changes. That is why the development of such drugs is extremely important for the development of modern medicine. According to available information, the drug will enter the pharmaceutical markets over the next five years.
